Christina L. Roland, MD, MS, FACS

Peer-Reviewed Articles

1. Malik N, Krause K, Keung EZ, Lyu HG, Lillemoe H, Scally C, Torres K, Hunt K, Austin M, Roland CL. Optimal surveillance for detecting sarcoma lung metastasis – A systematic review. Surgical Oncology Insight 2(1), 2025. e-Pub 2025.
2. Wang L, Li R, Wen A, Lu Q, Wang J, Ruan X, Gamboa A, Malik N, Roland CL, Katz MHG, Lyu H, Liu H. Discovering Signature Disease Trajectories in Pancreatic Cancer and Soft-tissue Sarcoma from Longitudinal Patient Records. medRxiv, 2025. e-Pub 2025. PMID: 40034771.
3. Tomczak, K, Patel, MS, Bhalla, A, Peterson, CB, Landers, S, Callahan, SC, Zhang, D, Wong, J, Landry, JP, Lazar, A, Livingston, JA, Guadagnolo, BA, Lyu, H, Lillemoe, HA, Roland, CL, Keung, EZ, Scally, CP, Hunt, KK, McCutcheon, IE, Slopis, JM, Gu, J, Scheet, PA, Wang, L, Rai, K, Torres, KE. Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Molecular Carcinogenesis 64(1):44-56, 2025. e-Pub 2025. PMID: 39600120.
4. Denu RA, Quintana-Perez CD, Wangsiricharoen S, Ingram DR, Wani KM, Lazar AJ, Ratan R, Roland CL, You Y. DNA mismatch repair deficiency as a biomarker in sarcoma 1(4), 2024. e-Pub 2024.
5. Lilley EJ, Yu W, Roland CL. Polycythemia in a Patient with a Large Retroperitoneal Leiomyoma. ACS Case Reviews, 2024. e-Pub 2024.
6. Lyu HG, Witt RG, Rajkot N, Keung EZ, Torres KE, Hunt KK, Somaiah N, Lazar AJ, Roland CL, Scally CP. Patterns of Care and Outcomes of Patients with Small Gastrointestinal Stromal Tumors at a High-Volume Sarcoma Center. Ann Surg Oncol 31(13):9258-9264, 2024. e-Pub 2024. PMID: 39230849.
7. Elmorsi R, Camacho L, Krijgh DD, Tilney GS, Lyu H, Traweek RS, Witt RG, Roubaud MS, Roland CL, Mericli AF. Optimizing Morbidity in Unplanned Soft Tissue Sarcoma Excisions: Should We Skip the Reconstructive Ladder?. Ann Plast Surg 93(3):361-368, 2024. e-Pub 2024. PMID: 38920187.
8. Bishop AJ, Mitra D, Farooqi A, Swanson DM, Hempel C, Willis T, Pearlnath C, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Guadagnolo BA. Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes. Cancer 131(1), 2024. e-Pub 2024. PMID: 39192597.
9. Gingrich A, Wangsiricharoen S, Torres MB, Ravi V, Ratan R, Keung EZ, Scally CP, Lazar AJ, Wang WL, Roland CL, Hunt KK, Yu W, Torres KE. Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas): Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol 31(12):7950-7956, 2024. e-Pub 2024. PMID: 39150618.
10. Awad A, Pal K, Yevich S, Kuban JD, Tam A, Odisio BC, Gupta S, Habibollahi P, Bishop AJ, Conley AP, Somaiah N, Araujo DM, Zarzour MA, Ratan R, Roland CL, Keung EZ, Huang SY, Sheth RA. Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver. Cancer 130(15):2703-2712, 2024. e-Pub 2024. PMID: 38642369.
11. Pal K, Awad A, Yevich S, Kuban JD, Tam A, Huang SY, Odisio BC, Gupta S, Habibollahi P, Bishop AJ, Conley AP, Somaiah N, Araujo D, Zarzour MA, Ravin R, Roland CL, Keung EZ, Sheth RA. Safety and Efficacy of Percutaneous Cryoablation for Recurrent or Metastatic Soft Tissue Sarcoma in Adult Patients. AJR Am J Roentgenol 223(4), 2024. e-Pub 2024. PMID: 39082849.
12. Nakazawa MS, Silverman IM, Rimkunas V, Veloso A, Glodzik D, Johnson A, Ohsumi TK, Patel SR, Conley AP, Roland CL, Soliman PT, Beird HC, Wu CC, Ingram DR, Lazcano R, Song D, Wani KM, Lazar AJ, Yap TA, Wang WL, Livingston JA. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Mol Cancer Ther 23(7):1057-1065, 2024. e-Pub 2024. PMID: 38561019.
13. NIHR Global Health Research Unit on Global Surgery, STARSurg Collaborative. A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score). The Lancet Digital Health 6(7):e507-e519, 2024. e-Pub 2024. PMID: 38906616.
14. Mericli AF, Elmorsi R, Camacho L, Hassan A, Krijgh DD, Tilney G, Lyu H, Traweek RS, Witt RG, Roubaud MS, Roland CL. When to ditch the ladder and take the elevator: The Anderson SArcoma Risk of Complications (A-SARC) score to guide reconstructive decision-making in extremity soft tissue sarcoma patients. J Surg Oncol 129(8):1456-1465, 2024. e-Pub 2024. PMID: 38623064.
15. Traweek RS, Lyu HG, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CL. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma. Ann Surg Oncol 31(6):4138-4147, 2024. e-Pub 2024. PMID: 38396039.
16. Nasr LF, Zoghbi M, Lazcano R, Nakazawa M, Bishop AJ, Farooqi A, Mitra D, Guadagnolo BA, Benjamin R, Patel S, Ravi V, Araujo DM, Livingston A, Zarzour MA, Conley AP, Ratan R, Somaiah N, Lazar AJ, Roland C, Keung EZ, Nassif Haddad EF. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers (Basel) 16(9), 2024. e-Pub 2024. PMID: 38730715.
17. Conley AP, Roland CL, Bessudo A, Gastman BR, Villaflor VM, Larson C, Reid TR, Caroen S, Oronsky B, Stirn M, Williams J, Burbano E, Coyle A, Barve MA, Wagle N, Abrouk N, Kesari S. BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer Gene Ther 31(4):517-526, 2024. e-Pub 2024. PMID: 38146006.
18. Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer 5(4):625-641, 2024. e-Pub 2024. PMID: 38351182.
19. Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland CL, Scally C, Keung E, Gandhi SN, Ashleigh Guadagnolo B, Nguyen QN, Bishop AJ. SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection. Int J Radiat Oncol Biol Phys 118(4):971-978, 2024. e-Pub 2024. PMID: 37914142.
20. Krijgh DD, Smith JM, Tilney G, Lyu H, Traweek RS, Witt RG, Roubaud MJ, Correa AM, Roland CL, Mericli AF. Identifying risk factors and analyzing reconstructive outcomes in patients with lower-extremity soft-tissue sarcoma. J Plast Reconstr Aesthet Surg 89:174-185, 2024. e-Pub 2024. PMID: 38199219.
21. Elmorsi R, Camacho L, Krijgh DD, Tilney GS, Lyu H, Traweek RS, Witt RG, Roubaud MS, Roland CL, Mericli AF. Sarcoma Size and Limb Dimensions Predict Complications, Recurrence, and Death in Patients with Soft Tissue Sarcoma in the Thigh: A Multidimensional Analysis. Ann Surg Oncol 31(8):5421-5430, 2024. e-Pub 2024. PMID: 38520583.
22. Nakazawa MS, Livingston JA, Zarzour MA, Bishop AJ, Ratan R, Ludwig JA, Araujo DM, Somaiah N, Ravi V, Nassif EF, Roland CL, Lazar AJ, Guadagnolo BA, Harrison DJ, Benjamin RS, Patel SR, Conley AP. Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort. Rare Tumors 16:20363613241271669, 2024. e-Pub 2024. PMID: 39105190.
23. Noh S, Nessim C, Keung EZ, Roland CL, Strauss D, Sivarajah G, Fiore M, Biasoni D, Cioffi SPB, Mehtsun W, Cananzi FCM, Sicoli F, Quagliuolo V, Chen J, Luo C, Gladdy RA, Swallow C, Johnston W, Ford SJ, Evenden C, Tirotta F, Almond M, Nguyen L, Rutkowski P, Krotewicz M, Pennacchioli E, Cardona K, Gamboa A, Hompes D, Renard M, Kollár A, Ryser CO, Vassos N, Raut CP, Fairweather M, Krakorova DA, Quildrian S, Perhavec A, Nizri E, Farma JM, Greco SH, Vincenzi B, Lopez JAG, Solerdecoll MS, Iwata S, Fukushima S, Kim T, Tolomeo F, Snow H, Howlett-Jansen Y, Tzanis D, Nikulin M, Gronchi A, Sicklick JK, Working Group TARS. Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg 278(2):267-273, 2023. e-Pub 2023. PMID: 35866666.
24. National Institute for Health and Care Research Global Health Research Unit on Global Surgery. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries. Br J Surg 110(7):804-817, 2023. e-Pub 2023. PMID: 37079880.
25. Bonvalot S, Roland C, Raut C, Le Péchoux C, Tzanis D, Frezza AM, Gronchi A. Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas. Eur J Surg Oncol 49(6):1061-1067, 2023. e-Pub 2023. PMID: 35599138.
26. Corn S, Nessim C, Roland CL, Gronchi A, Freeman C, Dumitra S. Data Dissemination of the Role of Neoadjuvant Radiation in Retroperitoneal Sarcoma: A CTOS and CSSO Survey. Curr Oncol 30(6):5807-5815, 2023. e-Pub 2023. PMID: 37366917.
27. Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ. Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Ann Surg Oncol 30(6):3668-3676, 2023. e-Pub 2023. PMID: 36723723.
28. Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res 29(9):1708-1718, 2023. e-Pub 2023. PMID: 37058010.
29. Cope BM, Traweek RS, Lazcano R, Keung EZ, Lazar AJ, Roland CL, Nassif EF. Targeting the Molecular and Immunologic Features of Leiomyosarcoma. Cancers (Basel) 15(7), 2023. e-Pub 2023. PMID: 37046760.
30. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2023. PMID: 36151848.
31. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol 30(2):926-940, 2023. e-Pub 2023. PMID: 36115928.
32. Keung EZ, Krause KJ, Maxwell J, Morris CD, Crago AM, Houdek MT, Kane J, Lewis V, Callegaro D, Miller B, Lazar AJ, Gladdy R, Raut CP, Fabbri N, Al-Refaie W, Fairweather M, Wong SL, Roland CL. Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature. Ann Surg Oncol 30(2):958-967, 2023. e-Pub 2023. PMID: 36307665.
33. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol 30(1):480-489, 2023. e-Pub 2023. PMID: 36085392.
34. Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
35. Traweek RS, Cope BM, Roland CL, Keung EZ, Nassif EF, Erstad DJ. Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma. Front Oncol 12:1006959, 2022. e-Pub 2022. PMID: 36439412.
36. NIHR Global Health Unit on Global Surgery, COVIDSurg Collaborative. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries. Lancet 400(10363):1607-1617, 2022. e-Pub 2022. PMID: 36328042.
37. Tseng WW, Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Ford SJ, Gonzalez RJ, Gladdy RA, Gyorki DE, Fairweather M, Lee KW, Albertsmeier M, van Houdt WJ, Fau M, Nessim C, Grignani G, Cardona K, Quagliuolo V, Grignol V, Farma JM, Pennacchioli E, Fiore M, Hayes A, Tzanis D, Skoczylas J, Almond ML, Mullinax JE, Johnston W, Snow H, Haas RL, Callegaro D, Smith MJ, Bouhadiba T, Desai A, Voss R, Sanfilippo R, Jones RL, Baldini EH, Wagner AJ, Catton CN, Stacchiotti S, Thway K, Roland CL, Raut CP, Gronchi A, Working Group TARS. Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol 29(12):7335-7348, 2022. e-Pub 2022. PMID: 35767103.
38. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
39. Witt RG, Cope B, Erstad DJ, Chiang YJ, Nassif EF, Scally CP, Torres KE, Hunt KK, Feig BW, Roland CL, Keung EZ. Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases. Ann Surg Oncol 29(11):7092-7100, 2022. e-Pub 2022. PMID: 35501583.
40. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol 23(9):1156-1166, 2022. e-Pub 2022. PMID: 35934010.
41. Uppal A, Kothari AN, Scally CP, Roland CL, Bednarski BK, Katz MHG, Vauthey JN, Chang GJ, Team D. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. JCO Oncol Pract 18(7):OP2100819, 2022. e-Pub 2022. PMID: 35263166.
42. DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
43. Deal CL, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman LA, Phillip M, Kim HS, Ko C, Malievskiy O, Cara JF, Roland CL, Taylor CT, Valluri SR, Wajnrajch MP, Pastrak A, Miller BS. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. J Clin Endocrinol Metab 107(7):e2717-e2728, 2022. e-Pub 2022. PMID: 35405011.
44. Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZ. Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center. Int J Cancer 150(12):2012-2024, 2022. e-Pub 2022. PMID: 35128664.
45. Boyce-Fappiano D, Damron EP, Farooqi A, Mitra D, Conley AP, Somaiah N, Araujo DM, Livingston JA, Ratan R, Keung EZ, Roland CL, Guadagnolo BA, Bishop AJ. Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions. Adv Radiat Oncol 7(3):100913, 2022. e-Pub 2022. PMID: 35647398.
46. Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CL. Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Ann Surg Oncol, 2022. e-Pub 2022. PMID: 35224688.
47. COVIDSurg Collaborative, GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia 77(1):28-39, 2022. e-Pub 2022. PMID: 34428858.
48. Loftus J, Yaworsky A, Roland CL, Turner-Bowker D, McLafferty M, Su S, Lamoureux RE. Experience of switching from a daily to a less frequent administration of injection treatments. PLoS One 17(11):e0278293, 2022. e-Pub 2022. PMID: 36449502.
49. Voss RK, Massarweh NN, Chiang YJ, Somaiah N, Feig BW, Roland CL. National Utilization of Imatinib in the Management of Resected Gastrointestinal Stromal Tumors. Ann Surg Oncol 28(13):9159-9168, 2021. e-Pub 2021. PMID: 34046772.
50. COVIDSurg Collaborative. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. Br J Surg 108(1):88-96, 2021. e-Pub 2021. PMID: 33640908.
51. Boughey JC, Snyder RA, Kantor O, Zheng L, Chawla A, Nguyen TT, Hillman SL, Hahn OM, Mandrekar SJ, Roland CL. Impact of the COVID-19 Pandemic on Cancer Clinical Trials. Ann Surg Oncol 28(12):7311-7316, 2021. e-Pub 2021. PMID: 34236550.
52. COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol 22(11):1507-1517, 2021. e-Pub 2021. PMID: 34624250.
53. Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Desai A, Gladdy RA, Gonzalez R, Gyorki DE, Fairweather M, van Houdt WJ, Stoeckle E, Park JB, Albertsmeier M, Nessim C, Cardona K, Fiore M, Hayes A, Tzanis D, Skoczylas J, Ford SJ, Ng D, Mullinax JE, Snow H, Haas RL, Callegaro D, Smith MJ, Bouhadiba T, Stacchiotti S, Jones RL, DeLaney T, Roland CL, Raut CP, Gronchi A, Working Group TAR. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group. Ann Surg Oncol 28(12):7873-7888, 2021. e-Pub 2021. PMID: 33852100.
54. COVIDSurg Collaborative, GlobalSurg Collaborative. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia 76(11):1454-1464, 2021. e-Pub 2021.
55. COVIDSurg Collaborative. Death following pulmonary complications of surgery before and during the SARC-CoV-2 pandemic. British Journal of Surgery 108(12):1448-1464, 2021. e-Pub 2021. PMID: 34871379.
56. Kochat V, Raman AT, Landers SM, Tang M, Schulz J, Terranova C, Landry JP, Bhalla AD, Beird HC, Wu CC, Jiang Y, Mao X, Lazcano R, Gite S, Ingram DR, Yi M, Zhang J, Keung EZ, Scally CP, Roland CL, Hunt KK, Feig BW, Futreal PA, Hwu P, Wang WL, Lazar AJ, Slopis JM, Wilson-Robles H, Wiener DJ, McCutcheon IE, Wustefeld-Janssens B, Rai K, Torres KE. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol 142(3):565-590, 2021. e-Pub 2021. PMID: 34283254.
57. Kantor, O, Chang, C, Yao, K, Boughey, JC, Roland, CL, Francescatti, A, Blair, SL, Dickson-Witmer, D, Hunt, KK, Nelson, H, Weiss, A, Oseni, T. Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Annals of surgical oncology 28(9):4995-5004, 2021. e-Pub 2021. PMID: 33423122.
58. Nepogodiev, D, Simoes, JF, Li, E, Glasbey, J, Picciochi, M, Kamarajah, S, Gujjuri, RR, Bhangu, A, Maryam, A, Azab, MA, Zahran, MA, Abdelaziz, AA, Aamir, J, Rahman, NA, Zaid, MA, Abaalkhail, M, Ababneh, A, Ababneh, H, Ababneh, L, Ababneh, R, Alonso, RA, Gurumeta, AA, Abad-Motos, A, Abaker, M, Abary, RR, Abass, A, Abate, E, Ahmed, SA, Abayomi, O, Abazeed, A, Abbad, B, Abbadessa, F, Abbadi, O, Abbakar, M, Abbas, AM, Abbas, AS, Abbas, A, Abbas, AM, Abbas, JD, Abbas, M, Abbas, MM, Abbas, O, Abbasov, A, Abbo, O, Gross, JL, Katz, MH, Kowalski, LP, Payet, ET, Roland, CL, Vartanian, JG. SARS-CoV-2 vaccination modelling for safe surgery to save lives. British Journal of Surgery 108(9):1056-1063, 2021. e-Pub 2021. PMID: 33761533.
59. Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, Aloia TA, Roland CL, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol 124(1):143-151, 2021. e-Pub 2021. PMID: 33751605.
60. COVIDSurg Collaborative, GlobalSurg Collaborative. Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study. Anesthesia 76(6):748-758, 2021. e-Pub 2021. PMID: 33690889.
61. Lee AJX, Purshouse K. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic. Br J Cancer 124(11):1777-1784, 2021. e-Pub 2021. PMID: 33767417.
62. Ratan R, Roland CL, Bishop AJ. Desmoid Fibromatosis: Management in an Era of Increasing Options. Curr Oncol Rep 23(4):41, 2021. e-Pub 2021. PMID: 33719012.
63. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat 186(3):871-882, 2021. e-Pub 2021. PMID: 33575859.
64. Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KE. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020. JAMA Netw Open 4(3):e210945, 2021. e-Pub 2021. PMID: 33734413.
65. Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist 26(3):250-260, 2021. e-Pub 2021. PMID: 33289298.
66. COVIDSurg Collaborative, GlobalSurg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surg 108(9):1056-1063, 2021. e-Pub 2021.
67. Glasbey JC, Bhangu A, Collaborative C. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. J Clin Oncol 39(1):66-78, 2021. e-Pub 2021. PMID: 33021869.
68. Keung EZ, Rajkot N, Torres KE, Somaiah N, Hunt KK, Feig BW, Scally CP, Ikoma N, Roland CL. Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum. Ann Surg Oncol 28(1):570-575, 2021. e-Pub 2021. PMID: 32409969.
69. COVIDSurg Collaborative. Delaying surgery for patients with a previous SARS-CoV-2 infection. Br J Surg 107(12):e601-e602, 2020. e-Pub 2020. PMID: 32974904.
70. Roland CL, van Houdt W, Gronchi A. The Landmark Series: Multimodality Treatment of Extremity Sarcoma. Ann Surg Oncol 27(10):3672-3682, 2020. e-Pub 2020. PMID: 32720044.
71. Patel RC, Downing C, Robinson C, Bassett R, Roland CL, Garg N, Cohen PR, MacFarlane DF. Dermatofibrosarcoma Protuberans Found Within Procedural Scars: A Retrospective Review at a Tertiary Referral Cancer Center. Cureus 12(9):e10286, 2020. e-Pub 2020. PMID: 33047078.
72. Tzeng CD, Tran Cao HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol 34:182-185, 2020. e-Pub 2020. PMID: 32891326.
73. Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: 32675511.
74. Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CD. Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg 220(1):140-146, 2020. e-Pub 2020. PMID: 31843190.
75. Bishop AJ, Landry JP, Roland CL, Ratan R, Feig BW, Moon BS, Zarzour MA, Wang WL, Lazar AJ, Lewis VO, Torres KE, Guadagnolo BA. Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies. Cancer 126(14):3265-3273, 2020. e-Pub 2020. PMID: 32343846.
76. Helmink BA, Roland CL, Kiernan CM, Wargo JA. Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon. Ann Surg Oncol 27(5):1533-1545, 2020. e-Pub 2020. PMID: 31965370.
77. Asare EA, Davis CH, Chiang YJ, Sabir S, Rajkot NF, Phillips PR, Roland CL, Torres KE, Hunt KK, Feig BW. Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin. J Surg Oncol 121(3):474-479, 2020. e-Pub 2020. PMID: 31846095.
78. Keung EZ, Burgess M, Salazar R, Parra ER, Rodrigues-Canales J, Bolejack V, Van Tine BA, Schuetze SM, Attia S, Riedel RF, Hu J, Okuno SH, Priebat DA, Movva S, Davis LE, Reed DR, Reuben A, Roland CL, Reinke D, Lazar AJ, Wang WL, Wargo JA, Tawbi HA. Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clin Cancer Res 26(6):1258-1266, 2020. e-Pub 2020. PMID: 31900276.
79. Petitprez F, de Reyniès A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougoüin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang WL, Lazar AJ, Roland CL, Wargo JA, Italiano A, Sautès-Fridman C, Tawbi HA, Fridman WH. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577(7791):556-560, 2020. e-Pub 2020. PMID: 31942077.
80. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma 2020:8363986, 2020. e-Pub 2020. PMID: 32565716.
81. Bishop AJ, Bird JE, Conley AP, Roland CL, Moon BS, Satcher RL, Livingston JA, Patel S, Wang WL, Lazar AJ, Lewis VO, Lin PP, Guadagnolo BA. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control. Am J Clin Oncol 42(10):744-748, 2019. e-Pub 2019. PMID: 31436747.
82. Yenikomshian MA, White AG, Carson ME, Jia ZB, Mendoza MR, Roland CL. Modeling the potential impact of abuse-deterrent opioids on medical resource utilization. J Med Econ 22(10):1073-1079, 2019. e-Pub 2019. PMID: 31314616.
83. Chrisinger JSA, Al-Zaid T, Keung EZ, Leung C, Lin HY, Roland CL, Torres KE, Benjamin RS, Ingram DR, Khan S, Somaiah N, Amini B, Feig BW, Lazar AJ, Wang WL. The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum. J Surg Oncol 22(10):1073-1079, 2019. e-Pub 2019. PMID: 31206726.
84. Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J. MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers (Basel) 11(5), 2019. e-Pub 2019. PMID: 31096717.
85. Cicero TJ, Mendoza M, Cattaneo M, Dart RC, Mardekian J, Polson M, Roland CL, Schnoll SH, Webster LR, Park PW. Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients. Postgrad Med 131(3):225-229, 2019. e-Pub 2019. PMID: 30794760.
86. Bishop AJ, Zarzour MA, Ratan R, Torres KE, Feig BW, Wang WL, Lazar AJ, Moon BS, Roland CL, Guadagnolo BA. Long-term outcomes for patients with desmoid fibromatosis treated with radiation therapy: a 10-year update and re-evaluation of the role of radiation therapy for younger patients. Int J Radiat Oncol Biol Phys 131(3):225-229, 2019. e-Pub 2019. PMID: 30552963.
87. Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo BA. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery. Am J Clin Oncol 42(3):238-242, 2019. e-Pub 2019. PMID: 30614820.
88. Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL. An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?. Am J Clin Oncol 42(2):160-165, 2019. e-Pub 2019. PMID: 30394881.
89. Roland CL, Ye X, Stevens V, Oderda GM. The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning. J Manag Care Spec Pharm 25(1):18-27, 2019. e-Pub 2019. PMID: 30589633.
90. Fonseca AL, Roland CL, Cormier JN, Torres KE, Hunt KH, Bishop AJ, Guadagnolo A, Feig BW. Radiation and Its Impact on Local Recurrence in Extremity and Trunk Well-Differentiated Liposarcomas. Am Surg 85(1):52-58, 2019. e-Pub 2019. PMID: 30760345.
91. Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer 124(23):4495-4503, 2018. e-Pub 2018. PMID: 30317543.
92. Ikoma N, Das P, Hofstetter W, Ajani JA, Estrella JS, Chen HC, Wang X, Callender RA, Zhu C, Roland CL, Fournier KF, Cormier JN, Mansfield P, Badgwell BD. Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching. Gastric Cancer 21(6):1004-1013, 2018. e-Pub 2018. PMID: 29730720.
93. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 18(1):913, 2018. e-Pub 2018. PMID: 30249211.
94. Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit. Ann Surg Oncol 25(8):2193-2200, 2018. e-Pub 2018. PMID: 29520652.
95. Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CL. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities. Ann Surg Oncol 25(5):1126-1132, 2018. e-Pub 2018. PMID: 29468609.
96. Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BW. Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center. Journal of Surg Onc 117(6):1188-1194, 2018. e-Pub 2018. PMID: 29228466.
97. Roland CL, Bednarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BW. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol 117(5):879-885, 2018. e-Pub 2018. PMID: 29448300.
98. Roland CL, Bernarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BW. Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. Journal of Surg Onc 117(5):879-885, 2018. e-Pub 2018.
99. Beird HC, Wu CC, Ingram DR, Wang WL, Alimohamed A, Gumbs C, Little L, Song X, Feig BW, Roland CL, Zhang J, Benjamin RS, Hwu P, Lazar AJ, Futreal PA, Somaiah N. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin. Cold Spring Harb Mol Case Stud 4(2), 2018. e-Pub 2018. PMID: 29610390.
100. Ikoma N, Roland CL, Cormier JN, Chiang YJ, Torres KE, Hunt KK, You YN, Feig BW. Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum. Am Surg 84(4):570-575, 2018. e-Pub 2018. PMID: 29712608.
101. Trans-Atlantic Retroperitoneal Sarcoma Working Group. Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Ann Oncol 29(4):857-871, 2018. e-Pub 2018.
102. Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BD. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base. Cancer 124(5):998-1007, 2018. e-Pub 2018. PMID: 29393964.
103. Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol 44(1):170-177, 2018. e-Pub 2018. PMID: 29208319.
104. Keung EZ, Tsai JW, Ali AM, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hunt KK, Wargo JA, Lazar AJ, Wang WL, Roland CL. Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy. Oncoimmunology 7(2):e1385689, 2018. e-Pub 2018. PMID: 29308306.
105. Smith SM, Jones JK, Katz NP, Roland CL, Setnik B, Trudeau JJ, Wright S, Burke LB, Comer SD, Dart RC, Dionne R, Haddox JD, Jaffe JH, Kopecky EA, Martell BA, Montoya ID, Stanton M, Wasan AD, Turk DC, Dworkin RH. Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations. J Pain 18(11):1287-1294, 2017. e-Pub 2017. PMID: 28479207.
106. Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CD, Chun YS, Feig BW, Vauthey JN, Conrad C. Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases. Ann Surg Oncol 25(1):107-116, 2017. e-Pub 2017. PMID: 29116489.
107. Voss RK, Chiang YJ, Torres KE, Guadagnolo BA, Mann GN, Feig BW, Cormier JN, Roland CL. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma. Ann Surg Oncol 24(11):3271-3278, 2017. e-Pub 2017. PMID: 28741122.
108. Yenikomshian MA, White AG, Carson ME, Garrison LP, Oderda GM, Biskupiak JE, Hlavacek PR, Roland CL. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients. J Opioid Manag 13(5):291-301, 2017. e-Pub 2017. PMID: 29199395.
109. Banerjee S, Roland CL, Willke R, Mardekian J, Garrison LP Jr. Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the US. J Pain Palliat Care Pharmacother 31(3-4):218-227, 2017. e-Pub 2017. PMID: 29261401.
110. Pasquale MK, Sheer RL, Mardekian J, Masters ET, Patel NC, Hurwitch AR, Weber JJ, Jorga A, Roland CL. Educational intervention for physicians to address the risk of opioid abuse. J Opioid Manag 13(5):303-313, 2017. e-Pub 2017. PMID: 29199396.
111. Ikoma N, Torres KE, Lin HY, Ravi V, Roland CL, Mann GN, Hunt KK, Cormier JN, Feig BW. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery. J Surg Oncol 116(3):313-319, 2017. e-Pub 2017. PMID: 28557016.
112. Livingston JA, Bugano D, Barbo A, Lin H, Madewell JE, Wang WL, Lazar AJ, Tseng WW, Roland CL, Feig BW, Pollock R, Conley AP, Benjamin RS, Patel S, Somaiah N. Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard. Sci Rep 7(1):11836, 2017. e-Pub 2017. PMID: 28928422.
113. Green JL, Bucher Bartelson B, Le Lait MC, Roland CL, Masters ET, Mardekian J, Bailey JE, Dart RC. Medical outcomes associated with prescription opioid abuse via oral and non-oral routes of administration. Drug Alcohol Depend 175:140-145, 2017. e-Pub 2017. PMID: 28414990.
114. Roszik J, Wang WL, Livingston JA, Roland CL, Ravi V, Yee C, Hwu P, Futreal A, Lazar AJ, Patel SR, Conley AP. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes. Clin Sarcoma Res 7(11), 2017. e-Pub 2017. PMID: 28630682.
115. Setnik B, Roland CL, Barsdorf AI, Brooks A, Coyne KS. The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain. Curr Med Res Opin 33(6):1067-1076, 2017. e-Pub 2017. PMID: 28277862.
116. Roland CL, Starker LF, Kang Y, Chatterjee D, Estrella J, Rashid A, Katz MH, Aloia TA, Lee JE, Dasari A, Yao JC, Fleming JB. Loss of DPC4/SMAD4 Expression in Primary Gastrointestinal Neuroendocrine Tumors is Associated with Cancer Related Death After Resection. Surgery 161(3):753-759, 2017. e-Pub 2017. PMID: 27816207.
117. Setnik B, Roland CL, Pixton G, Webster L. Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog Scales. J Clin Pharmacol 57(2):266-274, 2017. e-Pub 2017. PMID: 27444046.
118. Setnik B, Roland CL, Pixton GC, Sommerville KW. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain. Postgrad Med 129(1):5-11, 2017. e-Pub 2017. PMID: 27782769.
119. Roland CL, Setnik B, Brown DA. Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure. Postgrad Med 129(1):12-21, 2017. e-Pub 2017. PMID: 27960575.
120. Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg 126(1):1-11, 2017. e-Pub 2017. PMID: 27035165.
121. Roland CL, May CD, Watson KL, Al Sannaa GA, Dineen SP, Feig R, Landers S, Ingram DR, Wang WL, Guadagnolo BA, Feig B, Hunt KK, Cormier JN, Lazar AJ, Torres KE. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol 23(7):2220-8, 2016. e-Pub 2016. PMID: 26847678.
122. Roland CL, Boland GM, Demicco EG, Lusby K, Ingram D, May CD, Kivlin CM, Watson K, Al Sannaa GA, Wang WL, Ravi V, Pollock RE, Lev D, Cormier JN, Hunt KK, Feig BW, Lazar AJ, Torres KE. Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surg 151(4):347-54, 2016. e-Pub 2016. PMID: 26629783.
123. Dineen SP, Robinson KA, Roland CL, Beaty KA, Rafeeq S, Mansfield PF, Royal RE, Fournier KF. Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates. J Surg Res 200(1):158-63, 2016. e-Pub 2016. PMID: 26342838.
124. Fischer LK, Katz MH, Lee SM, Liu L, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Roland CL, Fleming JB, Estrella J, Rashid A, Wang H. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Histopathology 68(2):210-20, 2016. e-Pub 2016. PMID: 25945396.
125. Novak SP, Glasheen C, Roland CL. Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults. Subst Abuse Rehabil 7:87-98, 2016. e-Pub 2016. PMID: 27418863.
126. Roland CL, Katz MH, Tzeng CW, Lin H, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Vauthey JN, Crane CH, Lee JE, Fleming JB. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy. Ann Surg Oncol 22(Suppl 3):S1221-8, 2015. e-Pub 2015. PMID: 26350371.
127. Setnik B, Roland CL, Goli V, Pixton GC, Levy-Cooperman N, Smith I, Webster L. Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city. J Opioid Manag 11(6):463-73, 2015. e-Pub 2015. PMID: 26728643.
128. Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Sannaa GA, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, Torres KE. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions. Ann Surg Oncol 22(12):3913-20, 2015. e-Pub 2015. PMID: 25743327.
129. Brudvik KW, Patel SH, Roland CL, Conrad C, Torres KE, Hunt KK, Cormier JN, Feig BW, Aloia TA, Vauthey JN. Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. J Gastrointest Surg 19(8):1476-83, 2015. e-Pub 2015. PMID: 26001368.
130. Roland CL, Ross MI, Hall CS, Laubacher B, Upshaw J, Anderson AE, Lucci A. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study. Melanoma Res 25(4):335-41, 2015. e-Pub 2015. PMID: 26011119.
131. White AG, LeCates J, Birnbaum HG, Cheng W, Roland CL, Mardekian J. Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs. J Opioid Manag 11(3):199-210, 2015. e-Pub 2015. PMID: 25985805.
132. Roland CL, Yang AD, Katz MH, Chatterjee D, Wang H, Lin H, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JB. Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer. Ann Surg Oncol 22(4):1168-75, 2015. e-Pub 2015. PMID: 25352267.
133. Setnik B, Roland CL, Sommerville KW, Pixton GC, Berke R, Calkins A, Goli V. A multicenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide. J Pain Res 8:347-60, 2015. e-Pub 2015. PMID: 26185466.
134. Setnik B, Roland CL, Sommerville KW, Pixton GC, Berke R, Calkins A, Goli V. A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain. J Pain Res 8:361-73, 2015. e-Pub 2015. PMID: 26185467.
135. Rogin J, Wheless J, Abou-Khalil B, Wolter KD, Pixton GC, Sherman NA, Shukla RB, Roland CL, Sommerville KW. Safety and effectiveness of long-term treatment with diazepam auto-injector administered by caregivers in an outpatient setting for the treatment of acute repetitive seizures. Epilepsia 55(9):1444-51, 2014. e-Pub 2014. PMID: 24964913.
136. Roland CL, Arumugam T, Deng D, Liu SH, Philip B, Gomez S, Burns WR, Ramachandran V, Wang H, Cruz-Monserrate Z, Logsdon CD. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res 74(18):5301-10, 2014. e-Pub 2014. PMID: 24928781.
137. Cruz-Monserrate Z, Roland CL, Deng D, Arumugam T, Moshnikova A, Andreev OA, Reshetnyak YK, Logsdon CD. Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep 4:4410, 2014. e-Pub 2014. PMID: 24642931.
138. Philip B, Roland CL, Daniluk J, Liu Y, Chatterjee D, Gomez SB, Ji B, Huang H, Wang H, Fleming JB, Logsdon CD, Cruz-Monserrate Z. A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. Gastroenterology 145(6):1449-58, 2013. e-Pub 2013. PMID: 23958541.
139. Abou-Khalil B, Wheless J, Rogin J, Wolter KD, Pixton GC, Shukla RB, Sherman NA, Sommerville K, Goli V, Roland CL. A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia 54(11):1968-76, 2013. e-Pub 2013. PMID: 24111974.
140. Roland CL, Schwarz RE, Tong L, Ahn C, Balch GC, Yopp AC, Anthony T, Mansour JC. Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma?. Surgery 154(3):421-8, 2013. e-Pub 2013. PMID: 23972647.
141. Roland CL, Joshi AV, Mardekian J, Walden SC, Harnett J. Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States. J Opioid Manag 9(3):161-75, 2013. e-Pub 2013. PMID: 23771567.
142. Setnik B, Roland CL, Goli V, Sommerville K, Webster L. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients. J Opioid Manag 9(2):139-50, 2013. e-Pub 2013. PMID: 23709323.
143. Roland CL, Katz MH, Gonzalez GM, Pisters PW, Vauthey JN, Wolff RA, Crane CH, Lee JE, Fleming JB. A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma. J Gastrointest Surg 16(11):2056-63, 2012. e-Pub 2012. PMID: 22914983.
144. Rice JB, White AG, Birnbaum HG, Schiller M, Brown DA, Roland CL. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med 13(9):1162-73, 2012. e-Pub 2012. PMID: 22845054.
145. Roland CL, Bian A, Mansour JC, Yopp AC, Balch GC, Sharma R, Xie XJ, Schwarz RE. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. J Surg Oncol 105(6):595-600, 2012. e-Pub 2012. PMID: 22006521.
146. Roland CL, Mansour JC, Schwarz RE. Routine nasogastric decompression is unnecessary after pancreatic resections. Arch Surg 147(3):287-9, 2012. e-Pub 2012. PMID: 22430915.
147. Brown J, Setnik B, Lee K, Wase L, Roland CL, Cleveland JM, Siegel S, Katz N. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag 7(6):467-83, 2011. e-Pub 2011. PMID: 22320029.
148. Roland CL, Setnik B, Cleveland JM, Brown DA. Clinical outcomes during opioid titration following initiation with or conversion to Remoxy(R), an extended-release formulation of oxycodone. Postgrad Med 123(4):148-59, 2011. e-Pub 2011. PMID: 21680999.
149. Setnik B, Roland CL, Cleveland JM, Webster L. The abuse potential of Remoxy((R)), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodone. Pain Med 12(4):618-31, 2011. e-Pub 2011. PMID: 21463474.
150. Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 12(4):657-67, 2011. e-Pub 2011. PMID: 21392250.
151. Ou YH, Torres M, Ram R, Formstecher E, Roland CL, Cheng T, Brekken R, Wurz R, Tasker A, Polverino T, Tan SL, White MA. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol Cell 41(4):458-70, 2011. e-Pub 2011. PMID: 21329883.
152. Brown J, Setnik B, Lee K, Cleveland JM, Roland CL, Wase L, Webster L. Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting. J Pain Res 4:373-84, 2011. e-Pub 2011. PMID: 22090806.
153. Sullivan LA, Carbon JG, Roland CL, Toombs JE, Nyquist-Andersen M, Kavlie A, Schlunegger K, Richardson JA, Brekken RA. r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction. PLoS One 5(8):e12031, 2010. e-Pub 2010. PMID: 20700512.
154. Lynn KD, Udugamasooriya DG, Roland CL, Castrillon DH, Kodadek TJ, Brekken RA. GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer. BMC Cancer 10(397), 2010. e-Pub 2010. PMID: 20673348.
155. Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 120(7):2319-30, 2010. e-Pub 2010. PMID: 20577047.
156. Lynn KD, Roland CL, Brekken RA. VEGF and pleiotrophin modulate the immune profile of breast cancer. Cancers (Basel) 2(2):970-88, 2010. e-Pub 2010. PMID: 24281102.
157. Dineen SP, Roland CL, Greer R, Carbon JG, Toombs JE, Gupta P, Bardeesy N, Sun H, Williams N, Minna JD, Brekken RA. Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer. Cancer Res 70(7):2852-61, 2010. e-Pub 2010. PMID: 20332237.
158. McAdam-Marx C, Roland CL, Cleveland J, Oderda GM. Costs of opioid abuse and misuse determined from a Medicaid database. J Pain Palliat Care Pharmacother 24(1):5-18, 2010. e-Pub 2010. PMID: 20345194.
159. Roland CL, Dineen SP, Toombs JE, Carbon JG, Smith CW, Brekken RA, Barnett CC. Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts. Exp Biol Med (Maywood) 235(2):263-70, 2010. e-Pub 2010. PMID: 20404043.
160. Roland CL, Lynn KD, Toombs JE, Dineen SP, Udugamasooriya DG, Brekken RA. Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer. PLoS One 4(11):e7669, 2009. e-Pub 2009. PMID: 19888452.
161. Roland CL, Dineen SP, Lynn KD, Sullivan LA, Dellinger MT, Sadegh L, Sullivan JP, Shames DS, Brekken RA. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. Mol Cancer Ther 8(7):1761-71, 2009. e-Pub 2009. PMID: 19567820.
162. Dineen SP, Roland CL, Toombs JE, Kelher M, Silliman CC, Brekken RA, Barnett CC. The acellular fraction of stored platelets promotes tumor cell invasion. J Surg Res 153(1):132-7, 2009. e-Pub 2009. PMID: 18541268.
163. Roland CL, Lo CY, Miller BS, Holt S, Nwariaku FE. Surgical approach and perioperative complications determine short-term outcomes in patients with insulinoma: results of a bi-institutional study. Ann Surg Oncol 15(12):3532-7, 2008. e-Pub 2008. PMID: 18825460.
164. Dineen SP, Roland CL, Schwarz RE. Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison. HPB Surg 2008:719459, 2008. e-Pub 2008. PMID: 19197376.
165. MacLeod JB, Lefton J, Houghton D, Roland CL, Doherty J, Cohn SM, Barquist ES. Prospective randomized control trial of intermittent versus continuous gastric feeds for critically ill trauma patients. J Trauma 63(1):57-61, 2007. e-Pub 2007. PMID: 17622869.
166. Roland CL, Harken AH, Sarr MG, Barnett CC. ICAM-1 expression determines malignant potential of cancer. Surgery 141(6):705-7, 2007. e-Pub 2007. PMID: 17560245.
167. Roland CL. Partners for understanding pain: resources and toolkits to increase public awareness. J Pain Palliat Care Pharmacother 20(1):21-8, 2006. e-Pub 2006. PMID: 16687352.
168. Brixner DI, Oderda GM, Roland CL, Rublee DA. Opioid expenditures and utilization in the Medicaid system. J Pain Palliat Care Pharmacother 20(1):5-13, 2006. e-Pub 2006. PMID: 16687350.
169. Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K, Texter L. Body mass index and breast cancer risk in African American women. Ann Epidemiol 15(2):123-8, 2005. e-Pub 2005. PMID: 15652717.
170. Zhu K, Davidson NE, Hunter S, Yang X, Payne-Wilks K, Roland CL, Phillips D, Bentley C, Dai M, Williams SM. Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes. Cancer Causes Control 14(9):827-36, 2003. e-Pub 2003. PMID: 14682440.
171. Zhu K, Hunter S, Payne-Wilks K, Roland CL, Forbes DS. Use of electric bedding devices and risk of breast cancer in African-American women. Am J Epidemiol 158(8):798-806, 2003. e-Pub 2003. PMID: 14561670.
172. Beiler JS, Zhu K, Hunter S, Payne-Wilks K, Roland CL, Chinchilli VM. A case-control study of menstrual factors in relation to breast cancer risk in African-American women. J Natl Med Assoc 95(10):930-8, 2003. e-Pub 2003. PMID: 14620704.
173. Zhu K, Hunter S, Bernard LJ, Payne-Wilks K, Roland CL, Elam LC, Feng Z, Levine RS. An intervention study on screening for breast cancer among single African-American women aged 65 and older. Prev Med 34(5):536-45, 2002. e-Pub 2002. PMID: 11969355.
174. Zhu K, Hunter S, Bernard LJ, Payne-Wilks K, Roland CL, Levine RS. Recruiting elderly African-American women in cancer prevention and control studies: a multifaceted approach and its effectiveness. J Natl Med Assoc 92(4):169-75, 2000. e-Pub 2000. PMID: 10976173.
175. Ahmad S, Leavell ME, Fragen RJ, Jenkins W, Roland CL. Remifentanil versus alfentanil as analgesic adjuncts during placement of ophthalmologic nerve blocks. Reg Anesth Pain Med 24(4):331-6, 1999. e-Pub 1999. PMID: 10445772.
176. Warner DS, Hindman BJ, Todd MM, Sawin PD, Kirchner J, Roland CL, Jamerson BD. Intracranial pressure and hemodynamic effects of remifentanil versus alfentanil in patients undergoing supratentorial craniotomy. Anesth Analg 83(2):348-53, 1996. e-Pub 1996. PMID: 8694317.

Invited Articles

1. Lyu, H, Roland, CL, Scally, CP. ASO Author Reflections. Annals of surgical oncology 31(13):9285-9286, 2024. e-Pub 2024. PMID: 39320401.
2. Bonvalot S, Roland CL. ASO Author Reflections: The Landmark Series: Multimodal Management of Oligometastatic Sarcoma. Ann Surg Oncol 31(12):7967-7968, 2024. e-Pub 2024. PMID: 39230852.
3. Lyu HG, Snyder RA, Roland CL. ASO Author Reflections: Is a Patient's Home Address Associated with Survival Outcomes After Surgery for Extremity and Truncal Soft Tissue Sarcoma?. Ann Surg Oncol 31(6):4148-4149, 2024. e-Pub 2024. PMID: 38504045.
4. Miura J, Sabharwal S, Ghert M, Karakousis G, Roland CL. Great Debate: Systematic Re-Resection After Macroscopic Complete Unplanned Excision of Soft Tissue Sarcoma. Ann Surg Oncol 31(3):2047-2050, 2024. e-Pub 2024. PMID: 38112886.
5. Witt RG, Voss RK, Lewis VO, Roland CL, Keung EZ. ASO Author Reflections: Variability in Management of Sarcoma Lymph Node Metastases. Ann Surg Oncol 30(6):3677-3678, 2023. e-Pub 2023. PMID: 36749502.
6. Keung EZ, Hunt KK, Roland CL. ASO Author Reflections: A Call for Consensus, Collaboration and Data on the Role of Sentinel Lymph Node Biopsy for Soft Tissue Sarcoma. Ann Surg Oncol 30(2):968-969, 2023. e-Pub 2023. PMID: 36394686.
7. Traweek RS, Roland CL, Scally CP. ASO Author Reflections: Management of Patients with Soft Tissue Sarcoma Following Unplanned Excision. Ann Surg Oncol 30(1):490-491, 2023. e-Pub 2023. PMID: 36076129.
8. Witt RG, Roland CL, Keung EZ. ASO Author Reflections: Lymph Node Disease in Soft Tissue Sarcoma: A Problematic Clinical Dilemma. Ann Surg Oncol 29(11):7101, 2022. e-Pub 2022. PMID: 35486264.
9. Deming S, Francescatti A, Katz MHG, Roland CL. New Recommendations for the Technical Conduct of Cancer Surgery. Bull Am Coll Surg, 2022. e-Pub 2022.
10. Nassif E, Roland CL. Impactful Perioperative Clinical Trials Advance Sarcoma Care. ASCO Daily News, 2022. e-Pub 2022.
11. Voss RK, Massarweh NN, Roland CL. ASO Author Reflections: Imatinib Use Remains Inadequate for High-Risk GIST Patients. Ann Surg Oncol 28(13):9169-70, 2021. e-Pub 2021. PMID: 34018084.
12. Gyorki DE, Roland CL. ASO Author Reflections: Standardization in the Management of Retroperitoneal Sarcoma Through International Collaboration. Ann Surg Oncol 28(12):7889-7890, 2021. e-Pub 2021. PMID: 34089105.
13. Helmink B, Boughey JC, Roland CL. Neoadjuvant immunotherapy: Results in melanoma show promise and pave the way for other solid tumors. Bull Am Coll Surg 106(44):66-68, 2021. e-Pub 2021.
14. Gangi A, Roland CL, Snyder RA, Blackham AU. Preoperative radiotherapy for retroperitoneal sarcoma: Where do we go from here?. Bull Am Coll Surg 106, 2021. e-Pub 2021.
15. Roland CL, van Houdt W, Gronchi A. ASO Author Reflections: Moving the Needle in Extremity and Trunk Soft Tissue Sarcoma. Ann Surg Oncol 27(Suppl 3):899-900, 2020. e-Pub 2020. PMID: 32833151.
16. Keung EZ, Roland CL. ASO Author Reflections: Surveillance After Resection of Retroperitoneal Well-Differentiated Liposarcoma: A Balancing Act Between Earlier Recurrence Detection, Patient Anxiety, and Health Care Resource Expenditure. Ann Surg Oncol 27(Suppl 3):748-749, 2020. e-Pub 2020. PMID: 32409970.
17. Snyder RA, Roland CL, Boughey JC, Rocha FG. New trial aims to settle debate on the intensity of pancreatic cyst surveillance. Bull Am Coll Surg 105(6):73, 2020. e-Pub 2020.
18. Clarke C, Roland CL, Rocha FG. Modified FOLFIRINOX is superior to gemcitabine as adjuvant therapy for resected pancreatic cancer: The PRODIGE 24/CCTG PA6 Trial. Bull Am Coll Surg 105(1):76, 2020. e-Pub 2020.
19. Chawla A, Roland CL, Ferrone C. ALLIANCE A021806 examines perioperative vs. adjuvant chemotherapy for resectable pancreatic cancer. Bull Am Coll Surg 105(6):40, 2020. e-Pub 2020.
20. Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CW. Clinical trials-Designing, implementing, and collaborating. J Surg Oncol 122(1):25-28, 2020. e-Pub 2020. PMID: 32149390.
21. Roland CL. Soft Tissue Tumors of the Extremity. Surg Clin North Am 100(3):669-680, 2020. e-Pub 2020. PMID: 32402308.
22. Hao S, Snyder RA, Francescatti A, Roland CL. American College of Surgeons Clinical Research Program Sessions from the 2019 ACS Clinical Congress: A Recap. Bull Am Coll Surg 11(2), 2020. e-Pub 2020.
23. Sands J, Martin LW, Wigle D, Facktor M, Roland CL. ALCHEMIST trial has potential to improve outcomes after lung cancer resection. Bull Am Coll Surg 104(12), 2019. e-Pub 2019.
24. Ratan R, Bishop AJ, Roland CL. Evolution in the management of desmoid tumors: Challenging the role of upfront surgical resection. Bull Am Coll Surg 104(10), 2019. e-Pub 2019.
25. Snyder RA, Ikoma N, Boughey JC, Roland CL. Gastric Cancer: Recent Updates in Surgical and Multimodality Therapy. Bull Am Coll Surg 104(8), 2019. e-Pub 2019.
26. Fisher SB, Roland CL. ASO Author Reflections: Location-Specific Staging in Sarcoma-A Step in the Right Direction. Ann Surg Oncol 25(Suppl 3), 2018. e-Pub 2018. PMID: 30324474.
27. Soares KC, He J, Roland CL, Boughey JC. Immunotherapy in solid tumor. Bull Am Coll Surg 103(6):46-8, 2018. e-Pub 2018.
28. Ikoma N, Araujo D, Roland CL. The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste-Reply. JAMA Oncol 3(12):1740, 2017. e-Pub 2017. PMID: 28837712.
29. Roland CL, Wang WL, Lazar AJ, Torres KE. Myxofibrosarcoma. Surg Oncol Clin N Am 25(4):775-88, 2016. e-Pub 2016.
30. Roland CL, Hunt KK. Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States. Breast Diseases: a BD Quarterly 26(2):125-126, 2015. e-Pub 2015.

Manuals, Teaching Aids, Other Teaching Publications

1. . MD Anderson Cancer Treatment Algorithm-Breast Sarcoma, 2023.
2. . MD Anderson Cancer Treatment Algorithm-Adult Soft-Tissue Sarcoma for Clinical Stage III Extremity/Superficial Trunk, 2022.
3. Mehrazin R, Donahue TF, Liaw B, Kim EY, Jacob J Roland CL. GU Sarcoma. American Urologic Association University, 2021.
4. Roland CL. Site Specific Sarcoma. In Score-CGSO Curriculum, 2018.
5. Roland CL, Cormier JN. Surgical Management of Extremity and Truncal Sarcoma. In Complex General Surgical Oncology SSO Resource, 2017.

Other Articles

1. Morris ZS, Demaria S, Monjazeb AM, Formenti SC, Weichselbaum RR, Welsh J, Enderling H, Schoenfeld JD, Brody JD, McGee HM, Mondini M, Kent MS, Young KH, Galluzzi L, Karam SD, Theelen WSME, Chang JY, Huynh MA, Daib A, Pitroda S, Chung C, Serre R, Grassberger C, Deng J, Sodji QH, Nguyen AT, Patel RB, Krebs S, Kalbasi A, Kerr C, Vanpouille-Box C, Vick L, Aguilera TA, Ong IM, Herrera F, Menon H, Smart D, Ahmed J, Gartrell RD, Roland CL, Fekrmandi F, Chakraborty B, Bent EH, Berg TJ, Hutson A, Khleif S, Sikora AG, Fong L Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation. Lancet Oncol 26(3):e152-e170, 2025. PMID: 40049206.
2. Haddox, C, Hornick, JL, Roland, CL, Baldini, EH, Keedy, V, Riedel, RF Diagnosis and management of dedifferentiated liposarcoma. Cancer treatment reviews 131, 2024. PMID: 39454547.
3. Bonvalot, S, Tetreau, R, Llacer-Moscardo, C, Roland, CL The Landmark Series. Annals of surgical oncology 31(12):7930-7942, 2024. PMID: 39214938.
4. Gingrich A, Wangsiricharoen S, Torres MB, Ravi V, Ratan R, Keung EZ, Scally CP, Lazar AJ, Wang WL, Roland CL, Hunt KK, Yu W, Torres KE ASO Visual Abstract: Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas)-Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol, 2024. PMID: 39158635.
5. Kasper B, Baldini EH, Bonvalot S, Callegaro D, Cardona K, Colombo C, Corradini N, Crago AM, Dei Tos AP, Dileo P, Elnekave E, Erinjeri JP, Navid F, Farma JM, Ferrari A, Fiore M, Gladdy RA, Gounder M, Haas RL, Husson O, Kurtz JE, Lazar AJ, Orbach D, Penel N, Ratan R, Raut CP, Roland CL, Schut AW, Sparber-Sauer M, Strauss DC, Van der Graaf WTA, Vitellaro M, Weiss AR, Gronchi A Current Management of Desmoid Tumors: A Review. JAMA Oncol 10(8):1121-1128, 2024. PMID: 38900421.
6. Elmorsi R, Camacho L, Krijgh DD, Tilney GS, Lyu H, Traweek RS, Witt RG, Roubaud MS, Roland CL, Mericli AF ASO Visual Abstract: Sarcoma Size and Limb Dimensions Predict Complications, Recurrence, and Death in Patients with Soft Tissue Sarcoma in the Thigh-A Multidimensional Analysis. Ann Surg Oncol 31(8):5447-5448, 2024. PMID: 38719992.
7. Traweek RS, Lyu H, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CL ASO Visual Abstract: High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival Following Resection of Extremity and Truncal Soft-Tissue Sarcoma. Ann Surg Oncol 31(6):4150-4151, 2024. PMID: 38546800.
8. Schokrpur S, White MG, Roland CL, Patel SP Immuno-Oncology: New Insights into Targets and Therapies. Surg Oncol Clin N Am 33(2):265-278, 2024. PMID: 38401909.
9. Deal CL, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman LA, Phillip M, Kim HS, Ko C, Malievskiy O, Cara JF, Roland CL, Taylor CT, Valluri SR, Wajnrajch MP, Pastrak A, Miller BS Comparing the efficacy and safety of weekly somatrogon with daily somatropin to treat children with growth hormone deficiency: a plain language summary of publication. Ther Adv Endocrinol Metab 15:20420188241277404, 2024. PMID: 39526285.
10. Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membership. Ann Surg Oncol 30(6):3679-3680, 2023. PMID: 36826618.
11. Nassif EF, Roland CL, Keung EZ Reflections on the value of multidisciplinary oncology training by a medical oncologist. Eur J Surg Oncol 49(5):1046-1047, 2023. PMID: 36631346.
12. Keung EZ, Krause KJ, Maxwell J, Morris CD, Crago AM, Houdek MT, Kane J, Lewis V, Callegaro D, Miller B, Lazar AJ, Gladdy R, Raut CP, Fabbri N, Al-Refaie W, Fairweather M, Wong SL, Roland CL ASO Visual Abstract: Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas-A Systematic Review of the Literature. Ann Surg Oncol 30(2):970-971, 2023. PMID: 36323987.
13. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ ASO Visual Abstract: Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol 30(2):941-942, 2023. PMID: 36161369.
14. Gingrich AA, Nassif EF, Roland CL, Keung EZ The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Curr Oncol 30(2):2144-2158, 2023. PMID: 36826126.
15. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol 30(1):492, 2023. PMID: 36245056.
16. Callegaro D, Roland CL, Raut CP Relevant Trials Update in Sarcomas and Gastrointestinal Stromal Tumors: What Surgeons Should Know. Surg Oncol Clin N Am 31(3):341-360, 2022. PMID: 35715138.
17. Lewis, VO, Kemp, A, Roubaud, MJ, Ajay, D, Westney, OL, Smith, T, Dang, AQ, Hagan, K, Roland, CL, Penny, A, Adelman, DM Multidisciplinary Approach to Hemipelvectomy for Pelvic Sarcomas. JBJS reviews 10(5), 2022. PMID: 37544929.
18. Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CL ASO Visual Abstract: Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Ann Surg Oncol, 2022. PMID: 35254579.
19. Voss RK, Massarweh NN, Chiang YJ, Somaiah N, Feig BW, Roland CL ASO Visual Abstract: National Utilization of Imatinib in the Management of Resected Gastrointestinal Stromal Tumors. Ann Surg Oncol, 2021. PMID: 34050428.
20. Roland CL Sailing to the Mediterranean and Navigating Amyotrophic Lateral Sclerosis. JAMA Neurol 78(8):905-906, 2021. PMID: 34096983.
21. Setnik B, Schoedel KA, Levy-Cooperman N, Shram M, Pixton GC, Roland CL Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology. J Opioid Manag 13(6):485-523, 2017. PMID: 29308594.
22. Roland CL, Lake J, Oderda GM Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review. J Pain Palliat Care Pharmacother 30(4):258-268, 2016. PMID: 27802072.
23. Roland CL, Wang WL, Lazar AJ, Torres KE Myxofibrosarcoma. Surg Oncol Clin N Am 25(4):775-88, 2016. PMID: 27591498.
24. Oderda GM, Lake J, Rudell K, Roland CL, Masters ET Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review. J Pain Palliat Care Pharmacother 29(4):388-400, 2015. PMID: 26654413.
25. Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Degroot A, Edwards RR, Haddox DJ, Jaffe JH, Jones CM, Kleber HD, Kopecky EA, Markman JD, Montoya ID, O'Brien C, Roland CL, Stanton M, Strain EC, Vorsanger G, Wasan AD, Weiss RD, Turk DC, Dworkin RH Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain 154(11):2287-2296, 2013. PMID: 23792283.
26. Turk DC, O'Connor AB, Dworkin RH, Chaudhry A, Katz NP, Adams EH, Brownstein JS, Comer SD, Dart R, Dasgupta N, Denisco RA, Klein M, Leiderman DB, Lubran R, Rappaport BA, Zacny JP, Ahdieh H, Burke LB, Cowan P, Jacobs P, Malamut R, Markman J, Michna E, Palmer P, Peirce-Sandner S, Potter JS, Raja SN, Rauschkolb C, Roland CL, Webster LR, Weiss RD, Wolf K Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain 153(10):1997-2008, 2012. PMID: 22770841.
27. Low SJ, Roland CL Review of NMDA antagonist-induced neurotoxicity and implications for clinical development. Int J Clin Pharmacol Ther 42(1):1-14, 2004. PMID: 14756381.
28. . PMID: 12477150.
29. . PMID: 11110356.
30. . PMID: 16599372.

Editorials

1. Roland CL, Bonvalot S. Centralization of sarcoma surgery: Tailoring solutions beyond a one-size-fits-all approach. Eur J Surg Oncol 51(5):109609, 2025. PMID: 39862838.
2. Tzanis D, Roland CL. Is it possible to establish a calculable causal relationship between trauma and sporadic desmoid tumors?. Cancer 130(1):16-17, 2024. PMID: 37897628.
3. Roland CL. Maintaining Health-related Quality of Life for Desmoid Tumor Patients: The Proof is in the Data. Ann Surg 277(6):884-885, 2023. PMID: 36912036.
4. Roland CL. Optimizing Histology-Specific Clinical Trials in Soft-Tissue Sarcoma-Are We There Yet?. JAMA Oncol 8(10):1426-1427, 2022. PMID: 35980657.
5. Nassif E, Roland CL. Impactful Peri-operative Clinical Trials Advance Sarcoma Care. ASCO Daily Post, 2022.
6. Bishop AJ, Roland CL. Is quality related to quantity: Interpreting the results of STRASS in the context of noncompliant radiotherapy. Cancer 128(14):2701-2703, 2022. PMID: 35536110.
7. Lewis VO, Roland CL. Antibiotic Prophylaxis of Surgical Site Infections-A Double-edged Sword for Oncology Patients?. JAMA Oncol 8(3):340-342, 2022. PMID: 34989806.
8. Roland CL. What is the role of preoperative radiation in primary retroperitoneal sarcoma?. Surgery 170(1):318, 2021. PMID: 33342550.
9. Roland CL, Wong SL. Treatment for Advanced Soft Tissue Sarcoma: An Informative Neutral Trial. JAMA 323(13):1251-1252, 2020. PMID: 32259216.
10. Keung EZ, Roland CL. Window-of-Opportunity Trials: The Road Forward in Soft Tissue Sarcoma and Beyond. Ann Surg Onc 26(5):1188-1189, 2019. PMID: 30680475.
11. Keung EZ, Roland CL. Accurate and Reproducible Diagnosis of Canine Soft Tissue Sarcoma Using Mass Spectrometry: A Step in the Right Direction. Cancer Cell 34(5):697-699, 2018. PMID: 30423292.

Abstracts

1. Chelvanambi M, Deboever N, Nassif E, Damania A, Lili Chen L, Leung C, Keung E, Wu CC, Witt R, White M, Johnson S, Wong M, Mishra A, Lastrapes M, Somaiah N, Kadara H, Basu S, Allison J, Sharma P, McBride K, Fridman W, Heymach J, Sepesi B, Ajami N, Roland CL, Wargo J, Cascone T. Metagenomic sequencing reveals unique gut microbial features associated with tertiary lymphoid structures in response to immune checkpoint blockade in solid cancers. JITC 10(Suppl 2):A616, 2022. e-Pub 2022.
2. Nassif E, Liu B, Wang WL, Lazar A, Ingram D, Wani K, Duncan S, Tate T, Mathew G, Crosby S, Shaw K, Zelazowska M, Feig B, Torres K, Hunt K, Guadagnolo BA, Bishop A, Futreal AP, Wargo J, Somaiah N, McBride K, Roland CL, Keung EZ. B-cell receptor (BCR) repertoire is a dynamic biomarker of survival in sarcoma patients treated with neoadjuvant immune checkpoint blockade (ICB). JITC 10(Suppl 2):A566-A567, 2022. e-Pub 2022.
3. Traweek R, Witt R, Nassif E, Ajami N, Mishra A, Damania A, Chelvanambi M, Wang WL, Lazar A, Keung E, Torres K, Scally C, Zhang X, Daniel-MacDougall C, Wargo J, Somaiah N, Roland CL. Dietary fiber intake is associated with increased tertiary lymphoid structures in dedifferentiated liposarcoma following immune checkpoint blockade. JITC 10(Suppl 2):A649, 2022. e-Pub 2022.
4. Nassif EF, Chelvanambi M, Chen L, Wu CC, Damania A, Keung EZ, Witt RG, White M, Ajami NJ, Wong MC, Somaiah N, Sepesi B, Basu S, Allison JP, Sharma P, McBride K, Fridman WH, Wargo JA, Cascone T, Roland CL. Identifying gut microbial signatures associated with B cells and tertiary lymphoid structures (TLS) in the tumor microenvironment (TME) in response to immune checkpoint blockade (ICB) 40(16_suppl):2511, 2022. e-Pub 2022.
5. Keung EZ, Nassif EF, Lin HY, Lazar AJ, Torres KE, Wang WL, Guadagnolo BA, Bishop AJ, Hunt K, Feig BW, Bird JE, Lewis VO, Ratan R, Patel S, Zelazowska M, Liu B, McBride K, Wargo JA, Roland CL, Somaiah N. Randomized phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS): Survival results after 2 years of follow-up and intratumoral B-cell receptor (BCR) correlates. J Clin Oncol 40(17_suppl):LBA11501, 2022. e-Pub 2022.
6. Roland CL, Keung EZ, Lazar AJ, Torres KE, Wang WL, Guadagnolo A, Bishop AJ, Lin HY, Hunt K, Feig BW, Bird JE, Lewis VO, Tawbi HA, Ratan R, Patel S, Wargo JA, Somaiah N. Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS). J Clin Onc 38(15 Supp):11505, 2020. e-Pub 2020.
7. Roland CL, Yang K, Chatterjee D, Estrella J, Rashid A, Lee JE, Yao JC, Fleming JB. Loss of SMAD4 is associated with reduced survival in resected gastrointestinal neuroendocrine tumors 21(1):S94, 2014. e-Pub 2014.
8. Roland CL, Yang K, Chatterjee D, Estrella J, Rashid A, Lee JE, Yao JC, Fleming JB. Loss of SMAD4 is associated with reduced survival in resected gastrointestinal neuroendocrine tumors. Ann Surg Oncol 32 (Suppl 3):250, 2014. e-Pub 2014.
9. Arumugam T, Ramachandran V, Huang H, Fijii T, Roland CL, Rodriguez-Aguayo C, Berestein GL, Sood AK, Fleming JB, Abbruzzese JL, Sphyris N, Logsdon CD. Eradication of drug resistant cancer stem-like cells in PDAC. Pancreas 42(8):1337-38, 2013. e-Pub 2013.
10. Roland CL, Arumugam T, Deng D, Ramachandran V, Liu SH, Cruz-Monserrate Z, Logsdon CD. The lactate receptor, GPR81, is critical for pancreatic cancer cell survival in the tumor microenvironment. Ann Surg Oncol 20(1):S128, 2013. e-Pub 2013.
11. Roland CL, Ross MI, Hall CS, Laubacher B, Lucci A. Detection of circulating melanoma cells in the blood of melanoma patients: feasibility and preliminary significance. Ann Surg Oncol 20(1):S22, 2013. e-Pub 2013.
12. Roland CL, Katz MH, Gonzalez GM, Pisters PW, Vauthey JM, Crane C, Lee JE, Fleming JB. Influence of preoperative chemoradiation on biologically significant parameters in ampullary carcinoma. Ann Surg Oncol 19(1):S154, 2012. e-Pub 2012.
13. Roland CL, Lynn KD, Toombs JE, Dineen SP, Udugamasooriya DG, Brekken RA. Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer. Ann Surg Oncol 17(1):S43, 2010. e-Pub 2010.
14. Roland CL, Schwarz RE, Tong L, Ahn C, Balch GC, Yopp AC, Anthony T, Mansour JC. Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma?. Ann Surg Oncol 17(1):S117, 2010. e-Pub 2010.
15. Roland CL, Dineen SP, Lynn KD, Payton LA, Dellinger MA, Carbon JG, Toombs JE, Brekken RA. Tumor-derived VEGF regulates the recruitment of immune effector cells. Ann Surg Onc 16(1):14, 2009. e-Pub 2009.
16. Roland CL, Lo CY, Miller BS, Holt SA, Nwariaku FE. Surgical experience with non-insulinoma neuroendocrine Tumors: Results of a bi-institutional study. Ann Surg Onc 16(1):64, 2009. e-Pub 2009.

Book Chapters

1. Scally CP, Roland CL. Efficient, comprehensive patient care for multidisciplinary visits. In: Healthcare Delivery in Surgery: Scientific Principles and Practice. Wolters Kluwer, 212-216, 2023.
2. Voss RK, Roland CL. Soft Tissue Sarcoma. In: Fischer's Mastery of Surgery. 8. Lippincott, Williams and Wilkins, Chapter 72, 2023.
3. Witt RG, Roland CL. Soft-Tissue and Bone Sarcoma. In: The MD Anderson Surgical Oncology Manual. 7, 131-157, 2023.
4. Raval B, Jensen CT, Roland CL, Bishop AJ, Patel S. Primary Retroperitoneal Tumors. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier, 394-413, 2022.
5. Al-Refaie W, Callegaro D, Crago A, Fabbri N, Fairweather M, Gladdy R, Houdek M, Kane JM, Krause K, Lazar A, Lewis V, Maxwell JE, Miller B, Morris C, Raut CP, Silberfein EJ, Wong SL, Roland CL. Soft Tissue Sarcoma. In: Operative Standards in Cancer Surgery. Wolters Kluwer, 1-72, 2022.
6. Roland CL, Ross MI, Lazar AJ. Sarcomas of the Skin. In: Cancer of the Skin, Chapter 15, 2018.
7. Ikoma N, Roland CL, Feig BW. Soft-Tissue and Bone Sarcoma. In: The MD Anderson Surgical Oncology Handbook. 6th. Wolters Kluwer, 143-171, 2018.
8. Roland CL, Feig BW. History of GIST. In: Gastrointestinal Stromal Tumors: Bench to Bedside. Springer, 1-6, 2017.
9. Roland CL. Squamous cell vs adenocarcinoma of the esophagus. In: Complex General Surgical Oncology: A Case-Based Review. Future Medicine, 2014.
10. Roland CL. Adjuvant/neoadjuvant therapy for sarcoma. In: Complex General Surgical Oncology: A Case-Based Review. Future Medicine, 2014.
11. Roland CL. Resection vs. transplant for HCC. In: Complex General Surgical Oncology: A Case-Based Review. Future Medicine, 2014.
12. Roland CL. Oncology. In: Tarascon General Surgery Pocketbook. Jones & Barlett, 2012.
13. Roland CL, Frankel HL. Always consider domestic violence in women, elderly and pediatric victims of trauma. In: Avoiding Common Errors in the Emergency Department. Lippincott, Williams and Wilkins, 2010.
14. Roland CL, Barnett JR CC. Colorectal polyps. In: Abernathy's Surgical Secrets. 6th Edition. CV Mosby, 2009.
15. Roland CL, Klein J, McCarley C. Trauma Performance and Safety Improvement. In: The Parkland Trauma Handbook. 3rd. Edition. CV Mosby, 2009.
16. Lyu H, Roland CL. Resection of desmoid tumors and other fibromatosis. In: Difficult Decisions in Surgery: An Evidence-Based Approach.
17. Lyu HG, Patel SS, Lilley E, Raut CP, Roland CL. Sarcomas of the Soft Tissue, Retroperitoneum and Bone. In: Sabiston Textbook of Surgery. Elsevier.

Letters to the Editor

1. Setnik B, Roland CL, Webster L. Response to letter by Dr. Ruan. Pain Med 14: 161-2, 2013.